{"disease":{"id":"hyperlipidemia-mixed","name":"hyperlipidemia mixed"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01854918","title":"Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3681,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02662569","title":"Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":986,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07253584","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT02189837","title":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02275156","title":"Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05080140","title":"Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study","phase":"","overall_status":"UNKNOWN","enrollment_count":3,"lead_sponsor_name":"Misr University for Science and Technology","has_results":false},{"nct_id":"NCT02947334","title":"Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pfizer","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}